1-5 of 5
David A. Potter
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery

Kathy S. Albain, Christina Yau, Emanuel F. Petricoin, Denise M. Wolf, Julie E. Lang, A. Jo Chien, Tufia Haddad, Andres Forero-Torres, Anne M. Wallace, Henry Kaplan, Lajos Pusztai, David Euhus, Rita Nanda, Anthony D. Elias, Amy S. Clark, Constantine Godellas, Judy C. Boughey, Claudine Isaacs, Debu Tripathy, Janice Lu, Rachel L. Yung, Rosa I. Gallagher, Julia D. Wulfkuhle, Lamorna Brown-Swigart, Gregor Krings, Yunn Yi Chen, David A. Potter, Erica Stringer-Reasor, Sarah Blair, Smita M. Asare, Amy Wilson, Gillian L. Hirst, Ruby Singhrao, Meredith Buxton, Julia L. Clennell, Ashish Sanil, Scott Berry, Adam L. Asare, Jeffrey B. Matthews, Angela M. DeMichele, Nola M. Hylton, Michelle Melisko, Jane Perlmutter, Hope S. Rugo, W. Fraser Symmans, Laura J. van't Veer, Douglas Yee, Donald A. Berry, Laura J. Esserman
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (4): 729–740.
https://doi.org/10.1158/1078-0432.CCR-22-2256
Published: 16 February 2024
View article titled, Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery
Open the PDF for Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery in another window
Includes: Supplementary data
Journal Articles

A Neoadjuvant Chemotherapy Trial for Early Breast Cancer is Impacted by COVID-19: Addressing Vaccination and Cancer Trials Through Education, Equity, and Outcomes

David A. Potter, Alexandra Thomas, Hope S. Rugo
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (16): 4486–4490.
https://doi.org/10.1158/1078-0432.CCR-21-1133
Published: 15 August 2021
View article titled, A Neoadjuvant Chemotherapy Trial for Early Breast Cancer is Impacted by COVID-19: Addressing Vaccination and Cancer Trials Through Education, Equity, and Outcomes
Open the PDF for A Neoadjuvant Chemotherapy Trial for Early Breast Cancer is Impacted by COVID-19: Addressing Vaccination and Cancer Trials Through Education, Equity, and Outcomes in another window
Journal Articles

Sapanisertib Plus Exemestane or Fulvestrant in Women with Hormone Receptor–Positive/HER2-Negative Advanced or Metastatic Breast Cancer

Bora Lim, David A. Potter, Mohamad A. Salkeni, Paula Silverman, Tufia C. Haddad, Frederic Forget, Ahmad Awada, Jean-Luc Canon, Michael Danso, Alain Lortholary, Hugues Bourgeois, Elizabeth Tan-Chiu, Sylvie Vincent, Brittany Bahamon, Kevin J. Galinsky, Chirag Patel, Rachel Neuwirth, E. Jane Leonard, Jennifer R. Diamond
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2021) 27 (12): 3329–3338.
https://doi.org/10.1158/1078-0432.CCR-20-4131
Published: 15 June 2021
View article titled, Sapanisertib Plus Exemestane or Fulvestrant in Women with Hormone Receptor–Positive/HER2-Negative Advanced or Metastatic Breast Cancer
Open the PDF for Sapanisertib Plus Exemestane or Fulvestrant in Women with Hormone Receptor–Positive/HER2-Negative Advanced or Metastatic Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Prediction of Postoperative Recurrence-Free Survival in Non–Small Cell Lung Cancer by Using an Internationally Validated Gene Expression Model

Ranjana Mitra, Jinseon Lee, Jisuk Jo, Monica Milani, Jeanette N. McClintick, Howard J. Edenberg, Kenneth A. Kesler, Karen M. Rieger, Sunil Badve, Oscar W. Cummings, Ahmed Mohiuddin, Dafydd G. Thomas, Xianghua Luo, Beth E. Juliar, Lang Li, Clementina Mesaros, Ian A. Blair, Anjaiah Srirangam, Robert A. Kratzke, Clement J. McDonald, Jhingook Kim, David A. Potter
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (9): 2934–2946.
https://doi.org/10.1158/1078-0432.CCR-10-1803
Published: 01 May 2011
View article titled, Prediction of Postoperative Recurrence-Free Survival in Non–Small Cell Lung Cancer by Using an Internationally Validated Gene Expression Model
Open the PDF for Prediction of Postoperative Recurrence-Free Survival in Non–Small Cell Lung Cancer by Using an Internationally Validated Gene Expression Model in another window
Includes: Supplementary data
Journal Articles

Effects of HIV Protease Inhibitor Ritonavir on Akt-Regulated Cell Proliferation in Breast Cancer

Anjaiah Srirangam, Ranjana Mitra, Mu Wang, J. Christopher Gorski, Sunil Badve, LeeAnn Baldridge, Justin Hamilton, Hiromitsu Kishimoto, John Hawes, Lang Li, Christie M. Orschell, Edward F. Srour, Janice S. Blum, David Donner, George W. Sledge, Harikrishna Nakshatri, David A. Potter
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (6): 1883–1896.
https://doi.org/10.1158/1078-0432.CCR-05-1167
Published: 21 March 2006
View article titled, Effects of HIV Protease Inhibitor Ritonavir on Akt-Regulated Cell Proliferation in Breast Cancer
Open the PDF for Effects of HIV Protease Inhibitor Ritonavir on Akt-Regulated Cell Proliferation in Breast Cancer in another window